超越肺部:探索赫辛和安布罗克索尔的各种应用
Elham Ahmadi1, Arya Afrooghe1, Zahra Ebrahim Soltani2
1Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Life sciences
|July 12, 2024
概括
赫辛和安布罗克索尔通常用于呼吸系统疾病,显示出治疗肺外疾病的潜力,如神经和炎症性肠道疾病. 需要进一步的临床研究来确认它们的有效性超出了粘菌作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
- 药物重用 药物重用
背景情况:
- 多系统性疾病经常影响呼吸道,需要治疗呼吸道和非呼吸道症状.
- 赫辛和安布罗克索尔是已确立的粘膜溶解剂,在呼吸道疾病中具有有利的安全性.
- 新出现的证据表明,这些化合物具有超越粘膜清除的治疗性质.
研究的目的:
- 审查赫辛和安布罗克索尔在肺外的潜在应用.
- 探索使用这些药物在管理多系统疾病中的优势.
- 确定这些化合物的研究缺口和未来方向.
主要方法:
- 对1970年至2023年12月期间发表的研究进行了全面的文献搜索.
- 搜索的数据库包括PubMed,谷歌学者,Scopus,Embase和科克兰图书馆.
- 专注于研究肺外使用和潜在的治疗机制.
主要成果:
- 赫辛和安布罗克索尔在神经系统疾病和炎症性肠道疾病中显示出潜在的益处.
- 目前关于这些肺外应用的大部分研究都是临床前的.
- 除了粘菌效应之外,其确切的作用机制需要进一步阐明.
结论:
- 赫辛和安布罗克索尔可能为具有肺外表现的多系统性疾病提供治疗优势.
- 显著需要强大的临床试验来验证临床前发现.
- 赫辛和安布罗克索尔的药物重用对更广泛的治疗应用具有前景.
相关概念视频
Cholinergic Antagonists: Therapeutic Uses
739
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
739
Adrenergic Agonists: Therapeutic Uses
764
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
764
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
267
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
267
Drugs Used in Lower Respiratory Disorders: Overview
397
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
397
Antiasthma Drugs: Muscarinic Receptor Antagonists
280
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
280
Antiasthma Drugs: β2-Adrenoceptor Agonists
245
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
245


